Immediate postoperative evaluation of enteric anastomosis after the use of meloxicam in rats

Acta Cir Bras. 2016 May;31(5):320-6. doi: 10.1590/S0102-865020160050000005.

Abstract

Purpose: To compare ileal anastomoses in the immediate postoperative healing period after meloxicam use.

Methods: Forty two male Wistar rats were randomly divided into two groups of 21, COX and control group. To COX meloxicam in combination with morphine was given in 3 days period. Control group received only morphine during the same period. Each group was divided into three sub-groups of 7, which were euthanized at 5, 10, and 21 days postoperatively. Comparison was based in histological evaluation of collagen type I and III using sirius red, immunohistochemical through vascular endothelial growth factor and matrix metalloproteinase-9.

Results: Healing process in scheduled periods did not show significant differences (p>0.05) between the COX and control groups during any of the periods.

Conclusion: The use of meloxicam in the postoperative period following ileal anastomosis did not affect healing.

MeSH terms

  • Anastomosis, Surgical
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
  • Collagen Type I / metabolism
  • Collagen Type III / metabolism
  • Cyclooxygenase Inhibitors / pharmacology*
  • Ileum / blood supply
  • Ileum / surgery*
  • Male
  • Matrix Metalloproteinase 9 / drug effects
  • Matrix Metalloproteinase 9 / metabolism
  • Meloxicam
  • Models, Animal
  • Neovascularization, Physiologic / drug effects
  • Postoperative Period
  • Random Allocation
  • Rats, Wistar
  • Receptors, Vascular Endothelial Growth Factor / drug effects
  • Receptors, Vascular Endothelial Growth Factor / metabolism
  • Thiazines / pharmacology*
  • Thiazoles / pharmacology*
  • Time Factors
  • Wound Healing / drug effects*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Collagen Type I
  • Collagen Type III
  • Cyclooxygenase Inhibitors
  • Thiazines
  • Thiazoles
  • Receptors, Vascular Endothelial Growth Factor
  • Matrix Metalloproteinase 9
  • Meloxicam